Navigation Links
Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability
Date:12/14/2009

RIVIERA BEACH, Fla., Dec. 14 /PRNewswire/ -- Perry Baromedical, international leader in Hyperbaric Chamber manufacturing for 40 years, announces the launch of the Sigma Elite, with extended patient data capture capability. The advanced technology of the Sigma Elite is available on each monoplace chamber model currently available (www.perrybaromedical.com) and has a Patent Pending.

The Sigma Elite New "Smart Hyperbaric System" includes:

  • Data Capture Via Computerized System for Each Dive
  • Electronic (EMR) Medical Records Interface (Optional)
  • Individualized Patient Profiles
  • Visual Graphs in Real Time with Date & Time Log
  • Touch Screen Interface

According to Glenn Dennis, President/COO of Perry Baromedical, "the Sigma Elite now provides the ability for our chambers to provide Patient Data interface to EMR systems. This capability is unique and is in response to customer demand."

Standard features of the Sigma Elite Control and EMR System are:

  • Customizable Automated Treatment Protocols
  • Manual Treatments Captured for Future Use
  • Pneumatic Backup Control System
  • Analog Manual Set Point and Rate Set
  • Hard Copy of Treatment
  • Electronic Record of Treatment
  • Programmable Air Breath Alerts
  • Standard Treatment Profiles Pre-installed
  • Windows XPE Embedded Operating System
  • Split Screen Auxiliary Capability
  • Patient Record Dive Review

Perry Baromedical Corporation is dedicated to providing safe, cost effective and technologically advanced Hyperbaric Oxygen Chambers. Expertise and advanced technology along with proprietary manufacturing process and global resources, allow us to produce, ship, install and service the finest Hyperbaric Oxygen Chambers worldwide. Perry Baromedical is the only US hyperbaric ch
'/>"/>

SOURCE Perry Baromedical
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
(Date:5/20/2013)... GLENWOOD, Ill. , May 20, 2013 ... leader in personal and environmental radiation measurement and monitoring, ... accessories, announced today that its Board of Directors declared, ... quarterly cash dividend of $0.55 per share for the ... paid on July 3, 2013, to shareholders of record ...
(Date:5/20/2013)... , May 20, 2013   National Community Pharmacists ... , RPh, MBA issued the following statement today ... regarding Medicare Part D "preferred pharmacy" drug plans ... patients the plan,s lowest advertised co-payments: (Logo:  ... Medicare and MedPAC , 16 U.S. ...
Breaking Medicine Technology:North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4Landauer, Inc. Declares Regular Cash Dividend 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... (Nasdaq CM: SPEX), an innovator in biotechnology for ... providers of technical and regulatory consulting services to ... that the Company,s pharmaceutical product, D-tagatose, has been ... promising cardiovascular/metabolic therapies in development.  The selection was ...
... a developer and manufacturer of ultrahigh-brightness light sources for ... a clean manufacturing facility at its Massachusetts location. The ... assembly capability that will be used for optics assembly ... "Our new clean manufacturing space will give ...
Cached Medicine Technology:Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 2Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 3Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 4Energetiq Technology Implements Clean Manufacturing 2
(Date:5/21/2013)... Dimensional Insight, a developer of business intelligence ... Maryland Health System, a 275-bed hospital based in ... to help it analyze its data more quickly. Western ... Diver through Dimensional Insight’s recently announced partnership with ... Maryland has massive amounts of data in disparate systems, ...
(Date:5/21/2013)... AAG Health, the leading age management ... that it has acquired the OligoScan test made by ... advanced spectrophotometry technology, the OligoScan device is capable of ... 14 heavy metals, 20 trace elements (minerals), and oxidative ... substances such as mercury, lead, aluminum, and arsenic, will ...
(Date:5/21/2013)... ATS 2013, PHILADELPHIA The surgical management of non-small ... depending on the race of the patient, according to ... for Stage I and Stage II NSCLC is surgery," ... Medical Center in Omaha, Nebraska. "In our study of ... hospitals between the years 2000 and 2010, we found ...
(Date:5/21/2013)... After the success of its inaugural 1,000 ... Fit Body Boot Camp Goderich will be hosting its 2nd ... Goderich fitness center located at 199 Anglesea Street ... Challenge’s goal is to inspire and motivate local community residents ... The fee to participate is discounted to $40 for ...
(Date:5/21/2013)... Verdasys today announced availability ... (MSCD), a fully managed, outsourced service for companies ... malware and persistent cyber attacks from stealing sensitive data. ... data protection platform by making it available via a ... data transactions and systems events as well as data ...
Breaking Medicine News(10 mins):Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 2Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 4
... (NYSE: HB ) today announced its fiscal 2008 ... declared by Hillenbrand,s,Board of Directors on February 7, 2008, ... record at the close of business on March 17, ... is organized into two operating companies,serving the health care ...
... 6 times more likely to make mistakes , , FRIDAY, ... are about six times more likely to make medication errors ... a 123 pediatric residents at three children,s hospitals in the ... residents were depressed, and 74 percent were burned out. During ...
... CJPS Enterprises, LLC, (http://www.cjps-enterprises.com ) announced that it ... and licensing of intellectual property (IP)., The ... already,making its website available to universities, research organizations, ... "You have,to fill the shelves of the store ...
... Oversee Phase 3 Program of CGT-2168, ... Pharmaceuticals,Inc., today named a distinguished international panel ... Steering Committee charged with overseeing COGENT,the company,s ... its novel,combination antiplatelet product CGT-2168., (Logo: ...
... Mylan Inc. (NYSE: MYL ),today announced that Mylan ... judge in Florida finding that the inclusion of,Levothyroxine Sodium ... of legislative authority and that the product should be ... products available to pharmacies in Florida as soon,as motions ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
Cached Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... multi-drug test device provides clear, ... Negative results can be determined ... minutes; positive results require only ... urine sample application will dependably ...
... abuse tests are highly accurate in detecting the ... as confirmed by GC/MS testing. The assay provides ... method (such as GC/MS) must be used in ... should be applied to any drug of abuse ...
Medicine Products: